Sign Up to like & get
recommendations!
0
Published in 2021 at "Clinics and research in hepatology and gastroenterology"
DOI: 10.1016/j.clinre.2020.11.013
Abstract: OBJECTIVE α-fetoprotein is often used in the diagnosis of hepatocellular carcinoma (HCC). However, there are currently less efficient and highly specific biomarkers to distinguish AFP-negative HCC from liver cirrhosis (LC) patients. PATIENTS AND METHODS We…
read more here.
Keywords:
cirrhosis patients;
afp negative;
hcc;
negative hcc ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2023 at "Medicine"
DOI: 10.1097/md.0000000000033319
Abstract: This study aimed to formulate reliable nomograms for predicting the outcomes of α-fetoprotein (AFP)-negative hepatocellular carcinoma (HCC) patients after chemotherapy. HCC patients with normal AFP expression who received chemotherapy were screened and evaluated from the…
read more here.
Keywords:
hepatocellular carcinoma;
negative hepatocellular;
afp negative;
hcc patients ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "International journal of surgical pathology"
DOI: 10.1177/10668969221142038
Abstract: Hepatoid adenocarcinoma of the stomach is a rare histologic subtype of gastric carcinoma. Morphologically, it shows hepatocyte-like features and the tumor cells can show the expression of alpha-fetoprotein (AFP) in the tumor cells as well…
read more here.
Keywords:
adenocarcinoma stomach;
negative hepatoid;
afp negative;
hepatoid adenocarcinoma ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.e15681
Abstract: e15681 Background: Alpha-fetoprotein (AFP) is a major biomarker for diagnosis of hepatocellular carcinoma (HCC). Screening of molecular differences between AFP-negative and AFP-positive HCC can be helpful for its diagnosis. Methods: Genomic mutations, gene expressions and…
read more here.
Keywords:
hepatocellular carcinoma;
afp;
molecular differences;
differences afp ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1072775
Abstract: Background Early diagnosis for α-fetoprotein (AFP) negative hepatocellular carcinoma (HCC) remains a critical problem. Metabolomics is prevalently involved in the identification of novel biomarkers. This study aims to identify new and effective markers for AFP…
read more here.
Keywords:
hepatocellular carcinoma;
negative hcc;
negative hepatocellular;
hcc ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1131892
Abstract: Introduction As one of the most common malignant tumors in clinical practice, hepatocellular carcinoma (HCC) is a major threat to human health, where alpha-fetoprotein (AFP) is widely used for early screening and diagnoses. However, the…
read more here.
Keywords:
hepatocellular carcinoma;
nomogram model;
hcc;
afp negative ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Diagnostics"
DOI: 10.3390/diagnostics11122250
Abstract: Purpose: To explore the diagnostic value of Contrast-enhanced Ultrasound Liver Imaging Reporting and Data System version 2017 (CEUS LI-RADS v2017) in differentiating alpha-fetoprotein (AFP)-negative hepatocellular carcinoma (HCC) from other primary malignancies (OM) of the liver.…
read more here.
Keywords:
hcc;
afp negative;
value;
ceus ... See more keywords